Eur Respir J 1994; 7: 1172-1176
Copyright © ERS Journals Ltd 1994
Hypothesis: exposure to solvents may cause fibrosing alveolitis
CG Billings
and
P Howard
The incidence of fibrosing alveolitis, which can be caused by many agents, is increasing. In a proportion of patients, the aetiology is unknown (cryptogenic fibrosing alveolitis), but it has been suggested that environmental factors may play an important, but unrecognized, role in its pathogenesis. A review of the literature suggests that there may be a link between exposure to solvents, widespread occupational pollutants, and fibrosing alveolitis. Experimental work in animals has shown that exposure to solvents produces changes in the lung similar to those found in fibrosing alveolitis. Occupational exposure to a wide number of solvents has been associated with the development of systemic sclerosis. Pulmonary involvement in systemic sclerosis is morphologically indistinguishable from fibrosing alveolitis, and a close relationship between the two diseases seems to exist. This close relationship and the experimental work linking solvent exposure to fibrosing alveolitis suggest that solvent exposure may be one cause of cryptogenic fibrosing alveolitis. Determination of any occupational exposure of patients with cryptogenic fibrosing alveolitis may help in the understanding and prevention of this disease.
This article has been cited by other articles:

|
 |

|
 |
 
T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh
Diabetes Mellitus May Increase Risk for Idiopathic Pulmonary Fibrosis
Chest,
June 1, 2003;
123(6):
2007 - 2011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Kelly, S. S. Lok, P. S. Hasleton, J. J. Egan, and J. P. Stewart
A Rearranged Form of Epstein-Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
August 15, 2002;
166(4):
510 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Selman, T. E. King Jr., and A. Pardo
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Ann Intern Med,
January 16, 2001;
134(2):
136 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C Bourke and H. Clague
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines
Postgrad. Med. J.,
October 1, 2000;
76(900):
618 - 624.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. F. Robledo, R. S. Young, R. C. Lantz, and M. L. Witten
Short-Term Pulmonary Response to Inhaled JP-8 Jet Fuel Aerosol in Mice
Toxicol Pathol,
September 1, 2000;
28(5):
656 - 663.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. King
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement
Am. J. Respir. Crit. Care Med.,
February 1, 2000;
161(2):
646 - 664.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. P. STEWART, J. J. EGAN, A. J. ROSS, B. G. KELLY, S. S. LOK, P. S. HASLETON, and A. A. WOODCOCK
The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 1, 1999;
159(4):
1336 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the European Respiratory Society.
|